Live
Home·Deals·Biopharmaceuticals·Servier acquires Day One Biopharma
Servier acquires Day One Biopharma (2026)
SEO URLwww.firestrike.ai/deals/day-one-biopharma-servier-acquisition-2026-3
acquisitionAnnounced · Mar 6, 2026BiopharmaceuticalsSource · CredibleArticle · Factual
Day One Biopharma
Servier
Day One Biopharma · Servier

Servier acquires Day One Biopharma

David Najork
David Najork · Founding Software Engineer
Published · Updated · 1 min read
ShareXLinkedInEmail
Deal value
$2.5B
Target
Day One Biopharma
Day One Biopharma
NASDAQ: DAWN · Brisbane, California
Acquirer
Servier
Servier
Full Acquisition
Status
Announced

Servier agreed to acquire Day One Biopharma. Reported deal value: $2.5B. Status: Announced. Sector: Biopharmaceuticals. Target headquarters context: Brisbane, California, United States.

This page summarizes publicly available information about the transaction as of 2026-03-06. Figures and status may change as filings and press coverage update.

» Day One soars on $2.5B takeover deal with Servier Day One soars on $2.5B takeover deal with Servier March 6, 2026 No Comments Servier SAS is buying Day One Biopharmaceuticals Inc. for $21. 50 per share, which amounts to a total equity value of about $2.5 billion

Deal timeline

Announced
Mar 6, 2026 · bioworld.com
Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.
Sector context

This transaction is classified in Biopharmaceuticals with a reported deal value of $2.5B. Figures and status may change as sources update.

Sources: bioworld.com · Primary article · FireStrike proprietary index